MDM2 and neoplasm: There was a lower age (48.8 ± 1.63 vs. 54.5 ± 1.24 years, p = 0.007), more females (21/51 vs. 12/52, p = 0.049), larger tumor sizes (16.79 ± 4.03 vs. 6.63 ± 1.15 cm3, p = 0.018) and more invasive behavior (28/51 vs.16/52, p = 0.013) in high MDM2 patients than in low MDM2 patients.